Biortus Announces Strategic Collaboration with Schrödinger
Today, Biortus Biosciences Co. Ltd. (“Biortus”) announced a multi-year partnership with Schrodinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered
2024
/
03
Go BIG! - Purification and Structural Determination of RyR1, 2.3MDa membrane protein
With our state-of-the-art CryoEM facility and gene-to-structure pipeline, Biortus’s experienced team has solved a 2.8 Å CryoEM structure of RyR1, the largest known ion channel at 2.3 MDa.
2023
/
02
Biortus Delivering hERG Protein and Cryo-EM Structures
As part of the drug safety assessment practice, ion channels are one of the key family proteins under tight scrutiny with almost every drug candidate. Unfortunately, as of now the effect of drug candi
2022
/
04
Biortus Delivering ABCB10 Protein and Cryo-EM Structures
A member of ATP-binding cassette (ABC) transporter family located in the inner membrane of mitochondria, ABCB10 in the liver functions as a transporter of liver biliverdin, the reduction product of bilirubin (Fig. 1).
2022
/
04
Installed Krios G4 Boosts Productivity at Biortus CryoEM Center
Reporting from Wuxi, the long anticipated Titan Krios G4, the first of its kind in China, is now installed and operational at the Biortus CryoEM Center.
2021
/
05
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center
Biortus Biosciences Co. Ltd. (“Biortus”), a global leader in structural biology service for drug discovery, recently closed round A financing with US$15 million investment led by Bayland Capital, and the fund will be used to establish a global cryo-EM innovation center.
2020
/
10
CONTACT US
Telephone：+86 0510-86130005
Adresse：A5, 6 Dongsheng W. Rd., Jiangyin, Jiangsu, China
E-mail：info@biortus.bio
NEWS FEEDS
FOLLOW US
Copyright © 2020 Biortus Biosciences Co.,Ltd. 苏ICP备15024653号-1 Power by www.300.cn